GreenMark Biomedical Inc. — Form D/A
GreenMark Biomedical Inc. of EAST LANSING, MI, a company, filed a Form D amendment with the SEC on 2019-03-19. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-03-19
- Form: D/A
- Accession: 0001741718-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.2M
- Minimum investment: $25K
- Date of first sale: 2018-05-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-313147
Issuer
- Name: GreenMark Biomedical Inc.
- CIK: 0001741718
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 325 E. GRAND RIVER AVENUE SUITE 314, EAST LANSING, MI, 48823-4375
- Phone: 517-896-3665
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Steven Bloembergen, Ph.D. | Director | East Lansing, MI |
| Kenneth Pienta, M.D. | Director | East Lansing, MI |
| Michael D Snyder | Director | Pittsburgh, PA |
| Frank van Luttikhuizen, CPA | Director | East Lansing, MI |
| Steven Bloembergen, Ph.D. | Executive Officer | East Lansing, MI |
| Michael Snyder | Director | Jacksonville, FL |
| Michael Snyder | Related Person | Jacksonville, FL |
| Steven Bloembergen, PhD | Director | East Lansing, MI |
| Steven Bloembergen, PhD | Executive Officer | East Lansing, MI |
| Joerg Lahann, Ph.D. | Director | East Lansing, MI |
| Jeff Wesley | Director | Laingsburg, MI |
| Frank van Luttikhuizen | Director | East Lansing, MI |
| Steven Bloembergen | Director | East Lansing, MI |
| Steven Bloembergen | Executive Officer | East Lansing, MI |
| Kenneth Pienta | Director | East Lansing, MI |
| Steven Bloembergen PhD | Related Person | East Lansing, MI |
| Joerg Lahann, PhD | Related Person | East Lansing, MI |
Other filings by this issuer (5)
More